The expression of CD56 on malignant plasmocytes and bone disease in patients with multiple myeloma

被引：0
|
作者：
Buchler, Tomas [1 ]
Dolezelova, Eva [1 ]
Fabian, Pavel [2 ]
Pour, Ludek [1 ]
Moulis, Mojmir [3 ]
Kren, Leos [3 ]
Adam, Zdenek [1 ]
Krejci, Marta [1 ]
机构：
[1] Masaryk Univ Hosp, Dept Internal Med, Brno, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Pathol, Brno, Czech Republic
[3] Masaryk Univ Hosp, Inst Pathol Anat, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [1] THE ROLE OF CD56 EXPRESSION IN SMOLDERING MULTIPLE MYELOMA
    Notarfranchi, L.
    Storti, P.
    Vescovini, R.
    Segreto, R.
    Bonomini, S.
    Sammarelli, G.
    Todaro, G.
    Raimondi, V.
    Burroughs-Garcia, J.
    Toscani, D.
    Dalla Palma, A. B.
    Giuliani, N.
    HAEMATOLOGICA, 2022, 107 : 44 - 44
  • [2] The impact of CD56 expression in smoldering Multiple Myeloma
    Notarfranchi, Laura
    Vescovini, Rosanna
    Segreto, Roberta
    Bonomini, Sabrina
    Storti, Paola
    Marchica, Valentina
    Sammarelli, Gabriella
    Todaro, Giannalisa
    Soressi, Naomi
    De Giovanni, Dario
    Burroughs-Garcia, Jessica
    Toscani, Denise
    Palma, Anna Benedetta Dalla
    Giuliani, Nicola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S111 - S111
  • [3] THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
    Firsova, M.
    Mendeleeva, L.
    Kovrigina, A.
    Soloviev, M.
    Pokrovskaya, O.
    Nareyko, M.
    Kuzmina, L.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 795 - 796
  • [4] Retrospective Analysis of the Expression of CD56 in Multiple Myeloma with Bone-Related Extramedullary Diseases
    Chen, Qingjiao
    Zheng, Xiaoqiang
    Lin, Qiaoxian
    Chen, Junmin
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2023, 53 (01): : 14 - 20
  • [5] Prognostic significance of CD56 expression in patients with multiple myeloma: a meta-analysis
    Zhang, Lijuan
    Huang, Yun
    Lin, Yun
    Zhang, Aili
    Zou, Rong
    Xu, Huiying
    Wang, Sili
    HEMATOLOGY, 2022, 27 (01) : 122 - 131
  • [6] CD56 for Multiple Myeloma: Lack of CD56 May Be Associated with Worse Prognosis
    Miyazaki, Kanji
    Suzuki, Kenshi
    ACTA HAEMATOLOGICA, 2018, 140 (01) : 40 - 41
  • [7] Functional and Therapeutic Relevance of CD56(NCAM) Expression in Multiple Myeloma
    Gattenlohner, S.
    Mottok, A.
    Stuhmer, T.
    Bargou, R.
    Einsele, H.
    Muller-Hermelink, H-K
    LABORATORY INVESTIGATION, 2011, 91 : 297A - 297A
  • [8] Functional and Therapeutic Relevance of CD56(NCAM) Expression in Multiple Myeloma
    Gattenlohner, S.
    Mottok, A.
    Stuhmer, T.
    Bargou, R.
    Einsele, H.
    Muller-Hermelink, H-K
    MODERN PATHOLOGY, 2011, 24 : 297A - 297A
  • [9] CD56 expression is the potent prognostic marker of the thalidomide efficacy in the patients with multiple myeloma.
    Mori, A
    Tsutsumi, Y
    Hashino, S
    Kanamori, H
    Ibata, M
    Mashiko, S
    Masauzi, N
    Asaka, M
    Imamura, M
    BLOOD, 2005, 106 (11) : 368B - 369B
  • [10] The impact of CD56 expression in smoldering myeloma patients on early progression
    Notarfranchi, Laura
    Segreto, Roberta
    Vescovini, Rosanna
    Dalla Palma, Anna Benedetta
    Marchica, Valentina
    Burroughs-Garcia, Jessica
    Toscani, Denise
    Todaro, Giannalisa
    Raimondi, Vincenzo
    Iannozzi, Nicolas Thomas
    Bonomini, Sabrina
    Sammarelli, Gabriella
    Craviotto, Luisa
    Pedrazzoni, Mario
    Storti, Paola
    Giuliani, Nicola
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (03) : 587 - 589
12345